Astrana Health Inc (ASTH)

Cost of Revenue

$3.49B

TTM · Period ending: · USD

ASTH logo

ASTH Cost of Revenue

Latest reported$3.49B
ASTH TTM Cost of Revenue ($676.26M → $3.49B)
High-resolution chart · PNG

ASTH cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Astrana Health Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
3,489,668,000
3,198,009,000
2,872,235,000
2,602,544,000
2,133,311,000
1,976,718,000
1,763,152,000
1,475,014,000
1,345,171,000
1,217,801,000
1,171,703,000
1,110,767,000
1,076,160,000
1,013,354,000
944,687,000
863,407,000
770,112,000
676,256,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.